Market Overview

Alnylam, Tekmira Resolve All Litigation; Alnylam to Make $65M One-Time Payment

Related ALNY
Benzinga's Top Initiations
Cowen & Company Initiates Alnylam Pharmaceuticals With Outperform
Aegerion's Q4 Loss Narrows Y/Y, Ups Juxtapid Sales View - Analyst Blog (Zacks)
Related TKMR
The 3 Best Biotech Stocks Of The Last 30 Days
Tekmira Pharmaceuticals, Lakeland Industries Moving On Possible Ebola Case In California

Alnylam (NASDAQ: ALNY) and Tekmira Pharma (NASDAQ: TKMR) announced a settlement agreement that resolves all litigation between the companies, and has signed a new licensing agreement that restructures the relationship and provides clarity on all intellectual property and licensing issues between the companies. As a result of the restructuring and new agreements, Tekmira will receive $65 million within 10 days and is eligible to receive $10 million in near-term milestone payments expected to be received in 2013.

Posted-In: News Legal


Related Articles (ALNY + TKMR)

Around the Web, We're Loving...

Get Benzinga's Newsletters